Skip to content
Advertisement

A patient prepares to take the first of two combination pills, mifepristone, for a medication abortion during a visit to a clinic in Kansas City, Kan., on, Oct. 12, 2022. On Wednesday, Feb. 7, 2024, the medical journal Sage Perspectives retracted studies claiming to show the harms of mifepristone, citing conflicts of interest by the authors and flaws in the research. (AP Photo/Charlie Riedel, File)

A patient prepares to take the first of two combination pills, mifepristone, for a medication abortion during a visit to a clinic in Kansas City, Kan., on, Oct. 12, 2022. On Wednesday, Feb. 7, 2024, the medical journal Sage Perspectives retracted studies claiming to show the harms of mifepristone, citing conflicts of interest by the authors and flaws in the research. (AP Photo/Charlie Riedel, File)

Featured Photo Galleries